Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126219571 | 12621957 | 1 | I | 20160720 | 20160804 | 20160804 | EXP | CA-HQ SPECIALTY-CA-2016INT000651 | INTERCHEM | 66.00 | YR | F | Y | 0.00000 | 20160803 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126219571 | 12621957 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | U | 201749 | |||||||||
126219571 | 12621957 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | U | 0 | |||||||||
126219571 | 12621957 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 28.5714 MG (800 MG, 1 IN 4 W) | U | 0 | |||||||||
126219571 | 12621957 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
126219571 | 12621957 | 5 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
126219571 | 12621957 | 6 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | UNK | U | 0 | |||||||||
126219571 | 12621957 | 7 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | UNK | U | 0 | |||||||||
126219571 | 12621957 | 8 | C | FLOVENT | FLUTICASONE PROPIONATE | 1 | Unknown | UNK | U | 0 | |||||||||
126219571 | 12621957 | 9 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | UNK | U | 0 | ||||||||||
126219571 | 12621957 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
126219571 | 12621957 | 11 | C | RITUXIMAB | RITUXIMAB | 1 | Unknown | UNK | U | 0 | |||||||||
126219571 | 12621957 | 12 | C | ROSUVASTATIN CALCIUM. | ROSUVASTATIN CALCIUM | 1 | Unknown | UNK | U | 0 | |||||||||
126219571 | 12621957 | 13 | C | SALBUTAMOL | ALBUTEROL | 1 | Unknown | UNK | U | 0 | |||||||||
126219571 | 12621957 | 14 | C | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126219571 | 12621957 | 1 | Rheumatoid arthritis |
126219571 | 12621957 | 2 | Rheumatoid arthritis |
126219571 | 12621957 | 3 | Rheumatoid arthritis |
126219571 | 12621957 | 4 | Product used for unknown indication |
126219571 | 12621957 | 5 | Product used for unknown indication |
126219571 | 12621957 | 6 | Product used for unknown indication |
126219571 | 12621957 | 7 | Product used for unknown indication |
126219571 | 12621957 | 8 | Product used for unknown indication |
126219571 | 12621957 | 9 | Product used for unknown indication |
126219571 | 12621957 | 10 | Product used for unknown indication |
126219571 | 12621957 | 11 | Product used for unknown indication |
126219571 | 12621957 | 12 | Product used for unknown indication |
126219571 | 12621957 | 13 | Product used for unknown indication |
126219571 | 12621957 | 14 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126219571 | 12621957 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126219571 | 12621957 | Bone erosion | |
126219571 | 12621957 | C-reactive protein increased | |
126219571 | 12621957 | Drug hypersensitivity | |
126219571 | 12621957 | Hepatitis | |
126219571 | 12621957 | Liver disorder | |
126219571 | 12621957 | Pruritus | |
126219571 | 12621957 | Rash | |
126219571 | 12621957 | Red blood cell sedimentation rate increased | |
126219571 | 12621957 | Rheumatoid factor positive |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |